Biology subjects

Shain, K.

Publications and source records attributed to Shain, K..

3 recordsLinked to original sources

bioRxiv2025

Plasma cell identity escape drives resistance to anti-BCMA T-cell-redirecting therapy in multiple myeloma

Chimeric antigen receptor T-cell (CART) and T-cell engager (TCE) therapies targeting B-cell maturation antigen (BCMA) are transforming the treatment landscape for relapsed multiple myeloma (MM). However, despite impressive initial response rates, most patients eventually relapse. To investigate this unmet medical need, we applied whole-genome sequencing (WGS) to MM cells from cohorts of 102 relapsed patients treated with anti-BCMA CART and TCE therapies. Several genomic alterations were associated with clinical outcomes, particularly primary refractoriness, including high genomic complexity and mutations in genes regulating plasma cell identity, which predicted resistance to therapy. Single-cell RNA sequencing further revealed that MM cells from refractory patients exhibited high proliferation signatures and reduced expression of TNFRSF17 (encoding BCMA), while were less enriched for plasma cell-associated transcriptional programs, a phenomenon we term "plasma cell identity escape." This profile was strongly associated with immune dysregulation of CD8 T cells including increased activation and exhaustion. This evolution of MM toward a more proliferative and lineage-divergent state, refractory to the anti-BCMA T-cell redirecting therapies, was functionally validated in preclinical MM mouse models. Collectively, our results comprehensively define the cellular and molecular mechanisms underlying primary resistance to anti-BCMA therapies.

cancer biology↗

bioRxiv2024

TLCellClassifier: Machine Learning Based Cell Classification for Bright-Field Time-Lapse Images

Immunotherapies have shown promising results in treating patients with hematological malignancies like multiple myeloma, which is an incurable but treatable bone marrow-resident plasma cell cancer. Choosing the most efficacious treatment for a patient remains a challenge in such cancers. However, pre-clinical assays involving patient-derived tumor cells co-cultured in an ex vivo reconstruction of immune-tumor micro-environment have gained considerable notoriety over the past decade. Such assays can characterize a patients response to several therapeutic agents including immunotherapies in a high-throughput manner, where bright-field images of tumor (target) cells interacting with effector cells (T cells, Natural Killer (NK) cells, and macrophages) are captured once every 30 minutes for upto six days. Cell detection, tracking, and classification of thousands of cells of two or more types in each frame is bound to test the limits of some of the most advanced computer vision tools developed to date and requires a specialized approach. We propose TLCellClassifier (time-lapse cell classifier) for live cell detection, cell tracking, and cell type classification, with enhanced accuracy and efficiency obtained by integrating convolutional neural networks (CNN), metric learning, and long short-term memory (LSTM) networks, respectively. State-of-the-art computer vision software like KTH-SE and YOLOv8 are compared with TLCellClassifier, which shows improved accuracy in detection (CNN) and tracking (metric learning). A two-stage LSTM-based cell type classification method is implemented to distinguish between multiple myeloma (tumor/target) cells and macrophages/monocytes (immune/effector cells). Validation of cell type classification was done both using synthetic datasets and ex vivo experiments involving patient-derived tumor/immune cells. Availability and implementationhttps://github.com/QibingJiang/cell classification ml

cancer biology↗

bioRxiv2020

An Advanced Framework for Time-lapse Microscopy Image Analysis

Time-lapse microscopy is a powerful technique that generates large volumes of image-based information to quantify the behaviors of cell populations. This method has been applied to cancer studies to estimate the drug response for precision medicine and has great potential to address inter-patient (or intertumoral) heterogeneity. A couple of algorithms exist to analyze time-lapse microscopy images; however, most deal with very high-resolution images involving few cells (typically cell lines). There are currently no advanced and efficient computational frameworks available to process large-scale time-lapse microscopy imaging data to estimate patient-specific response to therapy based on a large population of primary cells. In this paper, we propose a robust and user-friendly pipeline to preprocess the images and track the behaviors of thousands of cancer cells simultaneously for a better drug response prediction of cancer patients. Availability and ImplementationSource code is available at: https://github.com/CompbioLabUCF/CellTrack ACM Reference FormatQibing Jiang, Praneeth Sudalagunta, Mark B. Meads, Khandakar Tanvir Ahmed, Tara Rutkowski, Ken Shain, Ariosto S. Silva, and Wei Zhang. 2020. An Advanced Framework for Time-lapse Microscopy Image Analysis. In Proceedings of BioKDD: 19th International Workshop on Data Mining In Bioinformatics (BioKDD). ACM, New York, NY, USA, 8 pages. https://doi.org/10.1145/nnnnnnn.nnnnnnn

bioinformatics↗